drugset / Trial / NCT00558077

Second-Line Treatments for Anovulatory Infertility in PCOS Patients

NCT00558077

Phase 4 Completed 50 enrolled University Magna Graecia
RandomizedParallel-groupOpen-labelTreatment

Summary

To date, it is still unclear the potential role of laparoscopic ovarian diathermy (LOD) in the management of polycystic ovary syndrome (PCOS)-related anovulatory infertility. Metformin administration, alone or combined with clomiphene citrate (CC), has shown to be an effective and attractive second-line treatment for ovulation induction in women with polycystic ovary syndrome (PCOS) after failure of CC treatment. The aim of the present study will be to compare in a randomized controlled fashion the efficacy of LOD with metformin plus CC administration in the treatment of the CC-resistant PCOS patients.

Timeline

Start
2003-02
Primary completion
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 150 mg
Subject Metformin Small molecule 1700 mg